Pink SheetThe US FDA last year challenged foreign cosmetics and hygiene firms to start following basic US drug GMP requirements for products that the agency regulates as drugs. Overseas consumer products firms
In VivoFinancings Biopharma firms raised a total of $4.8 billion in financing in the second quarter of 2016, a 16% decrease in value from Q1's $5.8 billion. Follow-on public offerings and early-stage venture